ELEVATION ONCOLOGY
Elevation Oncology makes genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Its lead candidate, seribantumab, which inhibits tumor growth driven by NRG1 fusions, is currently being clinically tested in the Phase 2 CRESTONE study for patients with tumors of any origin that have an NRG1 fusion.
ELEVATION ONCOLOGY
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.elevationoncology.com
Total Employee:
11+
Status:
Active
Contact:
(716) 371-1125
Email Addresses:
[email protected]
Total Funding:
147.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Elpiscience Biopharmaceuticals
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Elevation Oncology
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Elevation Oncology
venBio Partners
venBio Partners investment in Series B - Elevation Oncology
Qiming Venture Partners USA
Qiming Venture Partners USA investment in Series B - Elevation Oncology
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Elevation Oncology
Aisling Capital
Aisling Capital investment in Series B - Elevation Oncology
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Elevation Oncology
Samsara BioCapital
Samsara BioCapital investment in Series B - Elevation Oncology
BVF Partners
BVF Partners investment in Series B - Elevation Oncology
Vivo Capital
Vivo Capital investment in Series B - Elevation Oncology
Key Employee Changes
Official Site Inspections
http://www.elevationoncology.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.87 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elevation Oncology"
Elevation Oncology - Crunchbase Company Profile & Funding
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.See details»
Elevation Oncology Information - RocketReach
Elevation Oncology is a Biotechnology, and Drug Discovery company located in Boston, Massachusetts with $39.7 million in revenue and 25 employees. Find top employees, contact …See details»
Elevation Oncology | Governance
Governance Corporate Governance involves the processes and procedures used to manage the business affairs of a company and includes the structure and balance of power between the management and board. This section provides …See details»
Overview, News & Similar companies - ZoomInfo.com
View Elevation Oncology (www.elevationoncology.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Elevation Oncology - MedPath
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. …See details»
Elevation Oncology - 2025 Company Profile & Team - Tracxn
Jun 24, 2025 Elevation Oncology - Developer of precision medicine for the treatment of cancer. Public Company. Raised a total funding of $97.5M over 2 rounds from 15 investors.See details»
Elevation Oncology, Inc. - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Explore Elevation Oncology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 96 news, and 8 literature, Disease Domain:Neoplasms ...See details»
Elevation Oncology (USA) Funding: $197.5M
Jul 7, 2025 Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for...See details»
Elevation Oncology Company Profile - Office Locations ... - Craft
Oct 29, 2024 Elevation Oncology has 1 employees at their 1 location. See insights on Elevation Oncology including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Elevation Oncology - workinbiotech.com
Elevation Oncology is developing cancer therapies to target solid tumors. Cancers are characterized by uncontrolled growth. By understanding the drivers of this growth, Elevation …See details»
ELEVATION ONCOLOGY, INC. - SEC.gov
For questions regarding your stock ownership, you may contact our Corporate Secretary at [email protected] or, if you are a registered holder, our transfer …See details»
20200721_Elevation Oncology Launch PR.pdf
NEW YORK, NY – July 21, 2020 – Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically …See details»
Elevation Oncology: Revenue, Worth, Valuation & Competitors 2025
Elevation Oncology Revenue & Valuation Analysts estimate Elevation Oncology brings in $5.7M annually. Elevation Oncology's estimated revenue per employee stands at $124.7K. The most …See details»
Elevation Oncology | News Releases
Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical GroupSee details»
Elevation Oncology Appoints Experienced Clinical Development …
Mar 4, 2024 Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a …See details»
Elevation Oncology to Participate in Upcoming Investor Conferences
Feb 25, 2025 Leerink Global Biopharma Conference. Fireside chat on Tuesday, March 11, 2025 at 8:40 AM ET in Miami, FL. A live webcast and replay of the fireside chats will be available on …See details»
Elevation Oncology Announces Pricing of Initial Public Offering
Jun 24, 2021 Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically …See details»
Elevation Oncology to Present Preclinical Data for EO-1022 at the ...
We are leveraging our ADC expertise to advance EO-1022, a HER3 ADC for the treatment of patients with HER3-expressing solid tumors. EO-1022 is currently progressing through …See details»
Elevation Oncology | News Releases
Initial data showed promising signs of efficacy, including a 47.1% ORR in patients with resistant/refractory gastric cancer expressing Claudin 18.2, with a well-tolerated safety profile …See details»
Elevation Oncology | News Releases
Jun 15, 2021 Two precision medicine innovators to leverage genomic data from leading molecular diagnostics platform to identify actionable driver alterations, and jointly discover and …See details»